Episode #113 High Truths on Drugs and Addiction with Dr. Thomas McLellan on Pre-AddictionEpisode #113 High Truths on Drugs and Addiction with Dr. Thomas McLellan on Pre-Addiction
High Truths on Drugs and Addiction
Is it time to talk about Pre-Addiction? We have pre-diabetes and pre-glaucoma, diagnosis intended to prompt early treatment in order to prevent worse disease. Should we be diagnosing and treating Pre-Addiction? Thomas McLellan, Ph.D. has been a career researcher in addiction treatment and policy for 40 years, working primarily at the University of Pennsylvania and at the Treatment Research Institute (TRI) which founded and served as CEO for 25 years. From 2000-2009 he was Editor-in-Chief of the Journal of Substance Abuse Treatment. From 2009 to 2011, he was Deputy Director of the White House Office of National Drug Control Policy (ONDCP) where he formulated President Obama’s National Drug Control Strategy and helped include addiction treatment into the Affordable Care Act. In 2015-2016 he served as Senior Editor on the US Surgeon General’s Report, Facing Addiction. In his career he has published over 550 articles and chapters on addiction research and was awarded over 150 NIH research grants. He has been among the top ten most cited researchers in the addiction field for 15 years. Dr. McLellan is the recipient of several distinguished awards including the Lifetime Achievement Awards of the American, Italian, Australian, Egyptian and British Societies of Addiction Medicine; the Robert Wood Johnson Innovator Award; Distinguished Contribution to Addiction Medicine from the American Public Health Association, the American Medical Association; and jointly from the National Institutes of Drug Abuse and Alcoholism and Alcohol Abuse. He currently serves on the boards of Indivior LLC (makers of Suboxone) and Recover Together; and lives with his wife Kerry in Sarasota Florida. Pre-Addiction - A Missing Concept for Treating Substance Use Disorder, Aug 2022
1:11:40•20 Feb 2023
Pre-Addiction: A New Frontier in Early Treatment
“When the medical community became the drug dealers by prescribing opioids- and I'm one of them- we came to be part of the solution as well.”
Ever wondered if we could catch addiction before it takes hold? In this thought-provoking episode of 'High Truths on Drugs and Addiction', Dr. Roneet Lev sits down with Dr. Thomas McLellan, a veteran in addiction research and policy, to explore the concept of pre-addiction. Just like we have pre-diabetes and pre-glaucoma to spur early intervention, Dr. McLellan argues that recognizing pre-addiction could revolutionize how we approach substance abuse prevention. Dr.
McLellan brings four decades of experience from his roles at the University of Pennsylvania, the Treatment Research Institute, and even the White House. He dives into the evolution of addiction treatment, the pivotal role of the medical community, and the persistent stigma that surrounds addiction. The conversation doesn't shy away from controversial topics like marijuana's impact on mental health and the importance of community-based prevention strategies. With over 550 published articles and numerous awards under his belt, Dr.
McLellan's insights are both deep and actionable. He and Dr. Lev discuss how early diagnosis and treatment of pre-addiction could be a game-changer in combating the opioid epidemic and other substance abuse issues. They wrap up with a compelling call to action for listeners to consider the benefits of early intervention. If you're curious about innovative approaches to addiction prevention or want to understand the broader landscape of addiction treatment, this episode is a must-listen.
Tune in to gain a fresh perspective on how we can tackle addiction before it starts.
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.
Related Episodes
Similar episodes from other shows in the catalogue.